Paravision is providing face biometrics in a partnership with emaratech to deliver fast, on-the-move immigration checks at ...
President Trump received some rare good polling news Monday as a new survey shows him with his highest approval rating since early fall. The poll of likely voters by InsiderAdvantage shows 50% approve ...
President Trump’s approval rating has dropped 8 points since he started his second presidential term, according to an Emerson College Polling survey released Thursday. Forty-one percent of voters said ...
U.S. President Donald Trump's approval rating has fluctuated throughout his second term in the Oval Office but carries a downward trajectory, according to polls, with Gallup finding his approval mark ...
President Trump’s job approval rating has rebounded after a second-term low, according to new polling averages from Decision Desk HQ (DDHQ). The president’s approval rating in the DDHQ average of ...
President Trump's national approval rating is net negative, and among the lowest in modern history. Despite national trends, Trump maintains a net positive approval rating in 22 states, including ...
A new polling map has shown President Donald Trump’s approval ratings continue to reflect deep regional divides across the U.S. According to the latest state-by-state data compiled by Civiqs, only ...
President Donald Trump's approval ratings have remained about the same since last week as he continues to face diplomatic challenges, some controversial public messages on Christmas Day and ongoing ...
President Donald Trump's approval rating is net negative, among the lowest in modern presidential history. A recent NBC News poll shows a drop in enthusiasm for Trump among his MAGA base and ...
A new national poll is raising alarms for Democrats as the party works to rebound from last year's election setbacks. Only 18% of voters questioned in a Quinnipiac University survey released on ...
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...
The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results